Neeraj K Aryal

4PUBLICATIONS
60CO-AUTHORS
Molecular targetsHaematological tumoursTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Apr 15, 2026
Targeting the chromatin modifying enzyme, KDM5C, enhances AKT inhibition response in ER+ breast cancer.

Valentina Cutano, Shanade Dunn, Sungmi Park-Chouinard

|Sep 05, 2024
SETD1B mutations confer apoptosis resistance and BCL2 independence in B cell lymphoma.

Ana Portelinha, Shenqiu Wang, Sara Parsa

|Dec 01, 2020
Targeting Bfl-1 via acute CDK9 inhibition overcomes intrinsic BH3-mimetic resistance in lymphomas.

Scott Boiko, Theresa Proia, Maryann San Martin

|Aug 22, 2020
Daxx maintains endogenous retroviral silencing and restricts cellular plasticity in vivo.

Amanda R Wasylishen, Chang Sun, Sydney M Moyer

Pageof 1